(6aS,10R)-2-chloro-10-methyl-4-((methylsulfonyl)methyl)-6a,7,9,10-tetrahydro-6H-[1,4]oxazino[4,3-d]pyrimido[5,4-b][1,4]oxazine

Catalog No. :
ACKYSV178
CAS No. :
2161304-05-6
Molecular Formula :
C12H16ClN3O4S
Molecular Weight :
333.80

IUPAC Name:(6aS,10R)-2-chloro-10-methyl-4-((methylsulfonyl)methyl)-6a,7,9,10-tetrahydro-6H-[1,4]oxazino[4,3-d]pyrimido[5,4-b][1,4]oxazine

(6aS,10R)-2-chloro-10-methyl-4-((methylsulfonyl)methyl)-6a,7,9,10-tetrahydro-6H-[1,4]oxazino[4,3-d]pyrimido[5,4-b][1,4]oxazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$658.00Login to see priceInquiryInquiry
100mg98%$1648.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6aS,10R)-2-chloro-10-methyl-4-((methylsulfonyl)methyl)-6a,7,9,10-tetrahydro-6H-[1,4]oxazino[4,3-d]pyrimido[5,4-b][1,4]oxazine
IUPAC Name(6aS,10R)-2-chloro-10-methyl-4-((methylsulfonyl)methyl)-6a,7,9,10-tetrahydro-6H-[1,4]oxazino[4,3-d]pyrimido[5,4-b][1,4]oxazine
MDL No.MFCD31630397
Molecular FormulaC12H16ClN3O4S
Molecular Weight333.80
SMILESC[C@@H]1COC[C@H]2COC3=C(CS(C)(=O)=O)N=C(Cl)N=C3N21
InChI KeyLIWDXRLBRJOFFD-SFYZADRCSA-N
Synonym(6aS,10R)-2-Chloro-10-methyl-4-[(methylsulfonyl)methyl]-6a,7,9,10-tetrahydro-6H-[1,4]oxazino[4,3-d]pyrimido[5,4-b][1,4]oxazine
CAS No.2161304-05-6

Synthetic Route by SureRoute

1. ACKYSV178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZHPB257 route compound structure diagram
    ACZHPB25720277-69-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKYSV178 route product structure diagram
    ACKYSV1782161304-05-6
Inquiry

2. ACKYSV178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKYSV178 route product structure diagram
    ACKYSV1782161304-05-6
Inquiry

Comments (0)